首页> 美国卫生研究院文献>Interactive Cardiovascular and Thoracic Surgery >Static sac size with a type II endoleak post-endovascular abdominal aortic aneurysm repair: surveillance or embolization?
【2h】

Static sac size with a type II endoleak post-endovascular abdominal aortic aneurysm repair: surveillance or embolization?

机译:静态囊大小与II型内漏的血管内腹主动脉瘤修复:监视还是栓塞?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A best evidence topic was written according to a structured protocol. The question addressed was whether embolization is superior to surveillance for a type II endoleak associated with a static sac size post-endovascular abdominal aortic aneurysm repair (EVAR). Four hundred and sixty-one papers were identified, of which 10 papers presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, and relevant outcomes and results are tabulated. A review of the available literature suggests that most type II endoleaks are innocuous and will seal spontaneously during the long-term follow-up, even when they persist for more than 6 months. An analysis of the large European Collaborators on Stent-Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) registry that includes prospective data on 2463 patients from 87 European hospitals showed that type II endoleaks were not associated with an increased risk of rupture; this correlates well with the large single-centre studies included in this review. Based on the available evidence, we conclude that the management of most isolated type II endoleaks should be conservative—with close radiological follow-up—even when persistent, with intervention restricted to theoese associated with sac enlargement >5 mm over a 6-month period or >10 mm when compared with pre-EVAR diameter.
机译:根据结构化协议编写了​​最佳证据主题。所要解决的问题是,对于血管内腔腹主动脉瘤修复(EVAR)后静态囊大小而言,栓塞是否优于监测II型内漏。共鉴定出461篇论文,其中10篇论文是回答临床问题的最佳证据。将作者,期刊,出版日期和国家,研究的患者组,研究类型以及相关的结果和结果制成表格。对现有文献的回顾表明,大多数II型内漏无害,并且在长期随访中会自发封闭,即使持续超过6个月也是如此。欧洲大型协作者对支架移植技术进行主动脉瘤修复的研究分析(EUROSTAR),其中包括来自87家欧洲医院的2463名患者的前瞻性数据,显示II型内漏与破裂风险增加无关。这与本评价中包括的大型单中心研究很好地相关。根据现有证据,我们得出结论,即使在持续的情况下,大多数孤立的II型内漏的治疗也应是保守的-密切的放射学随访-即使在6个月的时间内,仅限于与囊扩张> 5 mm相关的可可囊肿进行干预或与EVAR之前的直径相比大于10毫米。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号